Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
Feb 2009 - Clin. Vaccine Immunol.; 16(2):1556-679X [PMID:19038780]
[Whiteside TL] [Piazza P] [Reiter A] [Stanson J] [Connolly NC] [Rinaldo CR] [Riddler SA]

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
Feb 2008 - Clin. Vaccine Immunol.; 15(2):1556-679X [PMID:17942609]
[Connolly NC] [Whiteside TL] [Wilson C] [Kondragunta V] [Rinaldo CR] [Riddler SA]